Hadolti, India

Abhijit Balaji Pawar

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Abhijit Balaji Pawar: Innovator in Pharmaceutical Compositions

Introduction

Abhijit Balaji Pawar is a notable inventor based in Hadolti, India. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on edaravone. His dedication to improving medical treatments has led to the development of a unique patent that addresses the stability of pharmaceutical compositions.

Latest Patents

Abhijit holds a patent for "Stable pharmaceutical compositions of edaravone." This invention relates to liquid pharmaceutical compositions of edaravone, specifically focusing on stable solutions for enteral administration. The composition is designed to remain stable for an extended period, which is crucial for effective treatment. The patent also encompasses methods for administration, processes for production, and the use of these compositions in treating diseases that are responsive to edaravone.

Career Highlights

Abhijit is currently associated with Slayback Pharma LLC, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company and the broader pharmaceutical community.

Collaborations

Abhijit collaborates with talented professionals such as Sushant Omprakash Dube and Girish G Kore. These partnerships enhance the research and development efforts at Slayback Pharma LLC, fostering an environment of innovation and progress.

Conclusion

Abhijit Balaji Pawar's contributions to the pharmaceutical industry, particularly through his patent on edaravone compositions, highlight his role as an influential inventor. His work not only advances medical treatments but also exemplifies the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…